Medical use of cannabis in Switzerland: analysis of approved exceptional licences

In recent years, the Swiss Federal Office of Public Health (FOPH) granted exceptional licenses for the medical use of cannabinoids, typically for 6 months with possible extensions. A systematic review of cannabinoids for medical use commissioned by the FOPH supports the use of cannabinoids for the treatment of chronic pain and spasticity. Exceptional licences for medical use of cannabinoids have increased substantially in Switzerland, with the programme including patients with a wide range of conditions.

The post Medical use of cannabis in Switzerland: analysis of approved exceptional licences appeared first on Weed World Magazine.

The Swiss Government Greenlit Trials to Assess the Need for New Cannabis Regulation

In order to appropriately regulate the drug in the future, Switzerland is conducting scientific trials with regular citizens to establish the health and safety of cannabis. The first thing to remember about Switzerland is that it’s not a member of the European Union, this is important because it means that it is not subject to […]

The post The Swiss Government Greenlit Trials to Assess the Need for New Cannabis Regulation appeared first on CBD Testers.